Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Carcinoid Syndrome”

44 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 44 results

Large-scale testing (Phase 3)Study completedNCT00412061
What this trial is testing

Everolimus and Octreotide in Patients With Advanced Carcinoid Tumor

Who this might be right for
Carcinoid TumorMalignant Carcinoid Syndrome
Novartis Pharmaceuticals 429
Testing effectiveness (Phase 2)Study completedNCT00853047
What this trial is testing

Study of Telotristat Etiprate (LX1606) in Participants With Symptomatic Carcinoid Syndrome Not Managed by Stable-Dose Octreotide Therapy

Who this might be right for
Carcinoid Syndrome
Lexicon Pharmaceuticals 23
Not applicableStudy completedNCT01234168
What this trial is testing

Assess Neuroendocrine Tumour (NET) Patients Currently Treated by Somatuline Autogel for History of Carcinoid Syndrome Associated With Episodes of Diarrhea

Who this might be right for
Neuroendocrine TumorsCarcinoid Syndrome
Ipsen 340
Testing effectiveness (Phase 2)WithdrawnNCT04776876
What this trial is testing

Retifanlimab (INCMGA00012) and Telotristat Ethyl for the Treatment of Advanced Neuroendocrine Tumors and Carcinoid Syndrome

Who this might be right for
Advanced Neuroendocrine NeoplasmCarcinoid Syndrome
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT01018953
What this trial is testing

Study to Assess the Efficacy and Safety of Different Doses of BIM 23A760 in Patients With Carcinoid Syndrome

Who this might be right for
Carcinoid Syndrome
Ipsen 8
Large-scale testing (Phase 3)Study completedNCT02063659
What this trial is testing

Telotristat Etiprate for Carcinoid Syndrome Therapy

Who this might be right for
Carcinoid Syndrome
Lexicon Pharmaceuticals 76
Large-scale testing (Phase 3)Looking for participantsNCT07087054
What this trial is testing

Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen

Who this might be right for
Carcinoid SyndromeCarcinoidCarcinoid Tumor+6 more
Crinetics Pharmaceuticals Inc. 141
Early research (Phase 1)Study completedNCT00020579
What this trial is testing

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 75
Testing effectiveness (Phase 2)Study completedNCT05361668
What this trial is testing

Study to Evaluate the Safety, PK, and Dose Response of Paltusotine in Subjects With Carcinoid Syndrome

Who this might be right for
Carcinoid SyndromeCarcinoidCarcinoid Tumor+6 more
Crinetics Pharmaceuticals Inc. 36
Testing effectiveness (Phase 2)WithdrawnNCT01172717
What this trial is testing

Study of Panitumumab in the Treatment of Carcinoid Syndrome

Who this might be right for
Carcinoid Syndrome
Boston Medical Center
Testing effectiveness (Phase 2)Study completedNCT02299089
What this trial is testing

Phase II Study of Subcutaneous Inj. Depot of Octreotide in Patients With Acromegaly and Neuroendocrine Tumours (NETs)

Who this might be right for
AcromegalyNeuroendocrine Tumors
Camurus AB 12
Large-scale testing (Phase 3)Study completedNCT02026063
What this trial is testing

Telotristat Etiprate - Expanded Treatment for Patients With Carcinoid Syndrome Symptoms

Who this might be right for
Carcinoid Syndrome
Lexicon Pharmaceuticals 124
Testing effectiveness (Phase 2)Study completedNCT03453489
What this trial is testing

AMT-PET in Monitoring Telotristat Etiprate Treatment in Participants With MetastaticNeuroendocrine Neoplasm

Who this might be right for
Carcinoid SyndromeMetastatic Nonfunctional Well Differentiated Neuroendocrine Neoplasm
Barbara Ann Karmanos Cancer Institute 4
Early research (Phase 1)Study completedNCT00005842
What this trial is testing

Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer

Who this might be right for
Cancer
National Cancer Institute (NCI) 24
Early research (Phase 1)Study completedNCT00005860
What this trial is testing

Oxaliplatin With Or Without Floxuridine and Leucovorin in Treating Patients With Metastatic Cancer of the Peritoneum

Who this might be right for
Cancer
Memorial Sloan Kettering Cancer Center
Not applicableStudy completedNCT05756608
What this trial is testing

Fibrosis in Chronic and Delayed Myocardial Infarction

Who this might be right for
Aortic StenosisChemotherapy Induced Systolic DysfunctionCarcinoid Syndrome
University of Edinburgh 50
Not applicableEnded earlyNCT04073017
What this trial is testing

Enterade in Carcinoid/Non-Carcinoid Syndrome Neuroendocrine Tumor Patients With Quality of Life Limiting Bowel Frequency

Who this might be right for
Neuroendocrine TumorCarcinoid Syndrome
Vanderbilt-Ingram Cancer Center 11
Large-scale testing (Phase 3)Study completedNCT01677910
What this trial is testing

TELESTAR (Telotristat Etiprate for Somatostatin Analogue Not Adequately Controlled Carcinoid Syndrome)

Who this might be right for
Carcinoid Syndrome
Lexicon Pharmaceuticals 135
Large-scale testing (Phase 3)Ended earlyNCT00092287
What this trial is testing

Comparison of Lanreotide Autogel® and Sandostatin LAR Depot in the Treatment of Clinical Symptoms Associated With Carcinoid Syndrome

Who this might be right for
Malignant Carcinoid Syndrome
Ipsen 4
Testing effectiveness (Phase 2)Ended earlyNCT01886287
What this trial is testing

P:II Above-Label Octreotide-LAR With Insufficiently Controlled Carcinoid Syndrome

Who this might be right for
Neuroendocrine Carcinoma
H. Lee Moffitt Cancer Center and Research Institute 2
Next Page